Trial intelligence / Profile preview

Inhaled insulin vs metformin and glimepiride in type 2 diabetes

NCT00469586Phase 3Terminated

Sponsor
Novo Nordisk
Start
Apr 2007
Primary completion
Apr 2008
Modality
Biologic
Countries
11
01

Overview

A Phase 3 trial of insulin human in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2007; status: terminated.

02

Drugs

insulin human
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00469586.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00469586.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call